Chase AIPricingFAQs
Display currency
Loading news…

Gallus BioPharmaceuticals

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
St Louis, Missouri, United States Founded 2010 1001-5000 employees For Profit

Gallus Biopharmaceuticals, LLC, a contract manufacturer, supplies clinical and commercial bulk biologics to the biopharmaceutical industry

Gallus BioPharmaceuticals was acquired by Patheon in 2014.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
5

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
3
Active products
6
IT spend
$9M

Company Info

Founded
2010
Employees
1001-5000
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
1
HQ
St Louis, Missouri, United States
Region
Midwestern US
Exit date
Aug 26, 2014

Signals & Scores

Heat score
High
Growth score
High
Trend (7d)
3.6
Trend (30d)
0
Trend (90d)
5.4
5
professional contacts at Gallus BioPharmaceuticals
Contact execs at Gallus BioPharmaceuticals

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Gallus BioPharmaceuticals

Loading news…

FAQs about Gallus BioPharmaceuticals

People who checked this page also checked these

Browse the full Acquirezy directory.
Gallus BioPharmaceuticals - Company Profile, Full Acquisitions List, Funding and Investments